𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epidermal growth factor receptor gene amplification and gefitinib sensitivity in patients with recurrent lung cancer

✍ Scribed by Hidefumi Sasaki; Katsuhiko Endo; Katsuhiro Okuda; Osamu Kawano; Naoto Kitahara; Hisaichi Tanaka; Akihide Matsumura; Keiji Iuchi; Minoru Takada; Masaaki Kawahara; Tomoya Kawaguchi; Haruhiro Yukiue; Tomoki Yokoyama; Motoki Yano; Yoshitaka Fujii

Book ID
106123792
Publisher
Springer-Verlag
Year
2007
Tongue
English
Weight
430 KB
Volume
134
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Comparative analysis of epidermal growth
Comparative analysis of epidermal growth factor receptor mutations and gene amplification as predictors of gefitinib efficacy in Japanese patients with nonsmall cell lung cancer
✍ Takashi Sone; Kazuo Kasahara; Hideharu Kimura; Kazuto Nishio; Masayuki Mizuguchi πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 235 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Because the investigation of epidermal growth factor receptor gene (__EGFR__) status as a predictor of gefitinib efficacy in Japanese patients has shown promise, the authors evaluated __EGFR__ mutations and gene amplification in biopsy specimens from Japanese patients wi

The impact of epidermal growth factor re
The impact of epidermal growth factor receptor gene status on gefitinib-treated Japanese patients with non-small-cell lung cancer
✍ Shuji Ichihara; Shinichi Toyooka; Yoshiro Fujiwara; Katsuyuki Hotta; Hisayuki Sh πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 403 KB πŸ‘ 2 views

## Abstract We investigated the relationships between genetic factors and clinical outcome in Japanese non‐small‐cell lung cancer (NSCLC) patients treated with gefitinib. Ninety‐eight NSCLC patients who had been treated with gefitinib, were screened for mutations in epidermal growth factor receptor